Component

Fasting glucose and HbA1c trajectory in adults with prediabetes

Species, preparation, dose and limitations are retained on linked claims.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. In a 12-week double-blind trial in adults with prediabetes, 2.4 g/day Moringa dry leaf powder produced favorable fasting-glucose and HbA1c change scores relative to placebo.

    Experimental context and source evidence
    dose
    2.4 g/day dry leaf powder or placebo
    duration
    12 weeks
    evidence_access
    Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
    evidence_scope
    literature_reviewed; model-specific source-derived curation
    experimental_model
    Sixty-five randomized adults with prediabetes
    limitations
    The modest trial reports relative change trajectories and does not identify the active constituent or establish diabetes treatment efficacy.
    nutrient_topic
    Moringa oleifera chapter; interacting nutrients, drugs, peptides and proteins retain their experimental settings. · Moringa oleifera
    organism
    Sixty-five randomized adults with prediabetes
    plain_language
    In a 12-week double-blind trial in adults with prediabetes, 2.4 g/day Moringa dry leaf powder produced favorable fasting-glucose and HbA1c change scores relative to placebo.
    primary_references
    Moringa oleifera Leaf Supplementation as a Glycemic Control Strategy in Subjects with Prediabetes. (2021). https://pubmed.ncbi.nlm.nih.gov/35010932/ DOI: 10.3390/nu14010057
    route
    Oral
    tissue
    Fasting blood glucose and HbA1c

    Moringa oleifera: mechanism of action and interactions (2026-09-20) · lines 134–143

    Original AI-assisted source-specific curation with primary-study citations, model, exposure, route, duration, negative findings and limitations preserved. Not publisher full text. · supports · Sixty-five randomized adults with prediabetes · source_derived_draft · unverified_draft

    ## moringa-prediabetes-glycemia In a 12-week double-blind trial in adults with prediabetes, 2.4 g/day Moringa dry leaf powder produced favorable fasting-glucose and HbA1c change scores relative to placebo. Model/species: Sixty-five randomized adults with prediabetes Tissue/system: Fasting blood glucose and HbA1c Exposure: 2.4 g/day dry leaf powder or placebo Route: Oral Duration: 12 weeks Limits: The modest trial reports relative change trajectories and does not identify the active constituent or establish diabetes treatment efficacy. Primary reference: Moringa oleifera Leaf Supplementation as a Glycemic Control Strategy in Subjects with Prediabetes. (2021). https://pubmed.ncbi.nlm.nih.gov/35010932/ DOI: 10.3390/nu14010057 Access: Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards